Of my 35 years in industry, the last 18 have been in clinical research, working in a variety of commercial and operational roles. During that time my focus, and that of the companies I have worked with, has always been the improvement of clinical trial conduct through better technology. My priority is to continually push the boundaries – enabling key stakeholders to be more efficient, more protocol compliant, and to collect high quality data that truly evaluates the investigational product’s efficacy and safety, while protecting patients.
During my journey in clinical research I have been centrally involved in two highly successful start-up – Firecrest Clinical and Longboat, and spent time with a leading CRO. My current company Advarra is well known for its commitment to patient safety and site centricity though its Review Services (IRB, IBC, EAC, DMC) and leading site- and sponsor-facing technology solutions.
This panel discussion is of great interest to me as the technology applied to Study Start-up processes, and the interconnectedness of this technology, is particularly critical in setting the stage for a successful clinical trial.